Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Investment Trust
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

BB Biotech AG

+ Add to Watchlist

BBAGF:US

Snapshot for BB Biotech AG (BBAGF)

Open: - High - Low: - Primary Exchange: OTC US
Volume: 0 52-Week Range: 267.0000 - 284.4408 Beta vs NBI: -

ETF Chart for BBAGF

No chart data available.
  • BBAGF:US 284.4408
  • 1M
  • 1Y
284.4408
Interactive BBAGF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BBAGF

BB Biotech AG is an investment company.The Company invests in biotech companies that operate in areas that include oncology, cardiovascular diseases, infectious diseases and autoimmune diseases.

Inception Date: Telephone: Tel: +41 44 267 67 00
Managers: DANIEL KOLLER
Web Site: www.bbbiotech.ch

Fundamentals for BBAGF

NAV -
Assets (M) -
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for BBAGF

Dividend Type Return of Capital
Dividend Frequency Annual
Last Dividend Net (on 2015-03-20) 11.6000
Dividend Yield (ttm) 4.18%

Performance for BBAGF

1-Month - 1-Year -
3-Month - 3-Year -
Year To Date - 5-Year -
Expense Ratio 1.02

Top Fund Holdings for BBAGF

Filing Date: 03/31/2015
Name Position Value % of Total
Celgene Corp 3,554,298 398,600,000 10.692%
Isis Pharmaceuticals Inc 5,729,426 354,900,000 9.520%
Incyte Corp 3,791,867 338,100,000 9.069%
Gilead Sciences Inc 2,865,596 273,600,000 7.339%
Actelion Ltd 2,402,424 270,500,000 7.256%
Agios Pharmaceuticals Inc 1,849,921 169,700,000 4.552%
Medivation Inc 1,274,706 160,100,000 4.294%
Vertex Pharmaceuticals Inc 1,334,445 153,100,000 4.107%
Radius Health Inc 3,722,140 149,000,000 3.997%
Neurocrine Biosciences Inc 3,201,552 123,700,000 3.318%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil